Carroll Financial Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $2.57M | Buy |
9,245
+2,417
| +35% | +$613K | 0.14% | 98 |
|
|
2021
Q3 | $1.58M | Buy |
6,828
+185
| +3% | +$45.7K | 0.09% | 142 |
|
|
2021
Q2 | $1.52M | Buy |
6,643
+46
| +0.7% | +$9.24K | 0.09% | 142 |
|
|
2021
Q1 | $1.23M | Sell |
6,597
-465
| -7% | -$91K | 0.08% | 149 |
|
|
2020
Q4 | $1.19M | Buy |
7,062
+153
| +2% | +$22.8K | 0.08% | 147 |
|
|
2020
Q3 | $1.02M | Sell |
6,909
-306
| -4% | -$47.4K | 0.08% | 149 |
|
|
2020
Q2 | $1.18M | Buy |
7,215
+330
| +5% | +$50.7K | 0.1% | 128 |
|
|
2020
Q1 | $955K | Buy |
6,885
+171
| +3% | +$23.5K | 0.09% | 133 |
|
|
2019
Q4 | $882K | Sell |
6,714
-14
| -0.2% | -$1.62K | 0.07% | 151 |
|
|
2019
Q3 | $752K | Sell |
6,728
-124
| -2% | -$13.8K | 0.07% | 169 |
|
|
2019
Q2 | $759K | Sell |
6,852
-3,567
| -34% | -$420K | 0.07% | 159 |
|
|
2019
Q1 | $1.35M | Buy |
10,419
+3,390
| +48% | +$412K | 0.13% | 100 |
|
|
2018
Q4 | $810K | Buy |
7,029
+91
| +1% | +$10.2K | 0.09% | 124 |
|
|
2018
Q3 | $744K | Buy |
6,938
+5
| +0.1% | +$500 | 0.08% | 142 |
|
|
2018
Q2 | $591K | Buy |
6,933
+251
| +4% | +$20.6K | 0.06% | 152 |
|
|
2018
Q1 | $517K | Buy |
6,682
+1
| +0% | +$81 | 0.06% | 163 |
|
|
2017
Q4 | $564K | Buy |
6,681
+1
| +0% | +$85 | 0.06% | 159 |
|
|
2017
Q3 | $585K | Sell |
6,680
-379
| -5% | -$31.1K | 0.07% | 141 |
|
|
2017
Q2 | $581K | Buy |
7,059
+1,951
| +38% | +$159K | 0.07% | 140 |
|
|
2017
Q1 | $429K | Buy |
5,108
+1
| +0% | +$80 | 0.05% | 162 |
|
|
2016
Q4 | $375K | Buy |
5,107
+980
| +24% | +$73K | 0.05% | 169 |
|
|
2016
Q3 | $331K | Buy |
4,127
+150
| +4% | +$12K | 0.05% | 180 |
|
|
2016
Q2 | $313K | Sell |
3,977
-300
| -7% | -$22.6K | 0.05% | 176 |
|
|
2016
Q1 | $307K | Hold |
4,277
| – | – | 0.06% | 175 |
|
|
2015
Q4 | $360K | Sell |
4,277
-297
| -6% | -$24.6K | 0.07% | 148 |
|
|
2015
Q3 | $352K | Buy |
4,574
+677
| +17% | +$57.2K | 0.08% | 148 |
|
|
2015
Q2 | $325K | Buy |
3,897
+2,930
| +303% | +$223K | 0.07% | 146 |
|
|
2015
Q1 | $70K | Buy |
967
+65
| +7% | +$4.63K | 0.03% | 235 |
|
|
2014
Q4 | $63K | Sell |
902
-497
| -36% | -$33.5K | 0.04% | 211 |
|
|
2014
Q3 | $94K | Sell |
1,399
-270
| -16% | -$17.1K | 0.03% | 226 |
|
|
2014
Q2 | $104K | Hold |
1,669
| – | – | 0.03% | 229 |
|
|
2014
Q1 | $98K | Buy |
1,669
+69
| +4% | +$3.85K | 0.03% | 217 |
|
|
2013
Q4 | $81K | Sell |
1,600
-1,342
| -46% | -$67.2K | 0.03% | 229 |
|
|
2013
Q3 | $148K | Buy |
2,942
+117
| +4% | +$6.13K | 0.06% | 163 |
|
|
2013
Q2 | $138K | Buy |
+2,825
| New | +$154K | 0.07% | 133 |
|
Other funds holding LLY
Carroll Financial Associates's LLY Position: Q4 2021 in Review
Carroll Financial Associates increased its Eli Lilly (LLY) stake by 35% in Q4 2021, buying an estimated $613K and bringing the position to 9,245 shares worth $2.57M. The position accounts for 0.14% of the portfolio, ranked #98.
Carroll Financial Associates first reported a position in LLY in Q2 2013 and has held it in 35 quarters since. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.
- Carroll Financial Associates held 9,245 shares of Eli Lilly worth $2.57M as of Q4 2021.
- Carroll Financial Associates bought 2,417 Eli Lilly shares in Q4 2021, an estimated $613K.
- Eli Lilly made up 0.14% of Carroll Financial Associates's portfolio in Q4 2021, its #98 holding.
- Carroll Financial Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 35 quarters since.
- 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.